results of retatrutide Retatrutide, an Amazing Future for Weight Loss 28.7% Weight Loss in New

S.EgelandE

(2013) 305:E134858

Counselling and management strategies Management is best framed as treating the symptom syndrome while maintaining the metabolic benefits of therapy when safe

With a growing number of patients using these medications for diabetes or to meet certain optimization goals before undergoing hip and knee reconstructive surgery, our aim was to establish evidence-based guidelines on when to discontinue these to enhance patient safety and surgical success. The study, Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty, obtained data from the TriNetX Research Network, a multi-institutional national aggregated database, to identify patients who underwent TKA or THA from January 1, 2018 to January 1, 2023